BB-10901 in Treating Patients With Relapsed and/or Refractory Multiple Myeloma
Clinical trial NCT00346255 · COMPLETED
Trial details
- NCT number
- NCT00346255
- Sponsor
- ImmunoGen, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-04-01
- Primary completion
- 2011-03-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.